2020
DOI: 10.1016/j.cryobiol.2020.01.006
|View full text |Cite
|
Sign up to set email alerts
|

Implications of variability in cell membrane permeability for design of methods to remove glycerol from frozen-thawed erythrocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 66 publications
0
3
0
Order By: Relevance
“…Analytical mass transport models have been widely used to simulate cell volume responses and CPA uptake during the exposure of cells to CPA solutions 5,6,8,19 . Modeling predictions can be used to avoid conditions that cause cells to shrink or swell beyond their osmotic tolerance limits and to compute the time needed to reach a sufficiently high enough intracellular CPA concentration to protect against freezing injury 11 .…”
Section: Discussionmentioning
confidence: 99%
“…Analytical mass transport models have been widely used to simulate cell volume responses and CPA uptake during the exposure of cells to CPA solutions 5,6,8,19 . Modeling predictions can be used to avoid conditions that cause cells to shrink or swell beyond their osmotic tolerance limits and to compute the time needed to reach a sufficiently high enough intracellular CPA concentration to protect against freezing injury 11 .…”
Section: Discussionmentioning
confidence: 99%
“…Current evidence suggested the presence of RBC sub-populations (e.g., oldest cells [31]) less resilient to cryopreservation-related injuries. The high variability in the glycerol permeability of the RBC membrane, and thus in the hemolysis after deglycerolization, between donors and within cells from the same donor [55], is further indicative of samples with low responsiveness to cryopreservation. In similarity to the currently known donor effects on the refrigerated storage lesion [56], small-scale studies at first, and then large donor-recipient cohorts studies are needed to understand the impact of donor factors on the efficacy and safety of frozen RBCs.…”
Section: What Nextmentioning
confidence: 99%
“…The need for greatly improved cryopreservation strategies for cells and tissues has increased dramatically during the past decade and this need has been driven by numerous advances in cellular and regenerative therapies [1][2][3][4]. Current cryopreservation strategies often employ a cryoprotective agent (CPA) such as dimethyl sulfoxide (DMSO) and glycerol [5][6][7][8][9][10][11][12][13][14]. These CPAs offer varying degrees of protection against the cellular injury associated with cryopreservation [15,16].…”
Section: Introductionmentioning
confidence: 99%